It's worth noting that this isn't about the type of insulin either - the NHS generally prescribes the new, fancy insulin analogues to type 1 diabetics as their first choice because they provide actual clinical benefits, despite this article's claim that they're a giant con that only exists to line the pharmaceutical industry's pockets. In particular, Lantus used to be the recommened long-acting insulin of choice for new patients until they switched to something even newer a few years back.